| scholarly article | Q13442814 |
| P50 | author | Anne C. Moorman | Q40385645 |
| P2093 | author name string | Kathleen N Ly | |
| Jian Xing | |||
| Fujie Xu | |||
| Reena Mahajan | |||
| Scott D Holmberg | |||
| Stephen J Liu | |||
| Chronic Hepatitis Cohort Study (CHeCS) Investigators | |||
| Loralee Rupp | |||
| P2860 | cites work | Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management | Q27001012 |
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Estimating the mortality rate of hepatitis C using multiple data sources | Q30983325 | ||
| Renal manifestations of hepatitis C infection | Q33586586 | ||
| Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors | Q33803919 | ||
| Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review | Q34754575 | ||
| Hepatitis C virus infection and the risk of coronary disease | Q34802706 | ||
| Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. | Q35886690 | ||
| The high comorbidity burden of the hepatitis C virus infected population in the United States | Q35927970 | ||
| Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. | Q35956072 | ||
| All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population | Q35974996 | ||
| Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008 | Q36100389 | ||
| Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population. | Q36497046 | ||
| Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis | Q37097794 | ||
| Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium | Q37656186 | ||
| ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions | Q38455863 | ||
| Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study | Q38466366 | ||
| Hepatitis C in the United States | Q42992102 | ||
| Increased Mortality Among Persons Infected With Hepatitis C Virus | Q43000320 | ||
| Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada | Q43041338 | ||
| Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence | Q43419544 | ||
| Associations of chronic hepatitis C with metabolic and cardiac outcomes | Q43447385 | ||
| Psychiatric disorders among veterans with hepatitis C infection | Q44081498 | ||
| The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. | Q44979610 | ||
| Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study | Q45227419 | ||
| Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus | Q45332364 | ||
| Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study | Q45356128 | ||
| Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study | Q58012228 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| chronic hepatitis | Q62019625 | ||
| P304 | page(s) | 1055-1061 | |
| P577 | publication date | 2014-02-12 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010. | |
| P478 | volume | 58 |
| Q40536482 | "Hep C, where art thou": What are the remaining (fundable) questions in hepatitis C virus research? |
| Q51765350 | A Descriptive Analysis of a Community Clinic Providing Hepatitis C Treatment to Poor and Uninsured Patients. |
| Q30250088 | APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. |
| Q98779307 | All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS) |
| Q57955412 | All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus |
| Q42048758 | Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease |
| Q38715525 | Changing trends in complications of chronic hepatitis C. |
| Q41667609 | Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010. |
| Q38797618 | Chronic hepatitis B and C infection in the United States: a review of current guidelines, disease burden and cost effectiveness of screening |
| Q41542344 | Chronic hepatitis C infection as a risk factor for renal cell carcinoma. |
| Q40588090 | Chronic hepatitis C virus (HCV) burden in Rhode Island: modelling treatment scale-up and elimination |
| Q40629916 | Chronic hepatitis C virus infection and the risk for diabetes: a community-based prospective study |
| Q26775011 | Chronic hepatitis C: This and the new era of treatment |
| Q50170882 | Cigarette Smoking in Persons Living with Hepatitis C: the National Health and Nutrition Examination Survey (NHANES), 1999-2014. |
| Q41486392 | Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease |
| Q41130579 | Cost-effectiveness of strategies for testing current hepatitis C virus infection |
| Q42386154 | Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States. |
| Q59361006 | Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population |
| Q58606990 | Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016 |
| Q33696050 | Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010 |
| Q92385797 | Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study |
| Q34681390 | HIV and hepatitis C mortality in Massachusetts, 2002-2011: spatial cluster and trend analysis of HIV and HCV using multiple cause of death |
| Q40528873 | Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals |
| Q54208089 | Hepatitis C in Canada and the importance of risk-based screening. |
| Q39877443 | Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma |
| Q39760683 | Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2013. |
| Q48289018 | Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality |
| Q64118240 | Impact of ICD-10-CM Transition on Mental Health Diagnoses Recording |
| Q93068104 | Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013 |
| Q41039250 | Increase in nonhepatic diagnoses among persons with hepatitis C hospitalized for any cause, United States, 2004-2011. |
| Q35558268 | Labour productivity losses caused by premature death associated with hepatitis C in Spain. |
| Q54205778 | Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings. |
| Q31136569 | Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registry |
| Q90728225 | Monitoring liver transplant rates in persons diagnosed with hepatitis C: a data linkage study, England 2008 to 2017 |
| Q92293636 | Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016 |
| Q39138199 | Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis |
| Q40169020 | Neighborhood Inequalities in Hepatitis C Mortality: Spatial and Temporal Patterns and Associated Factors |
| Q40690948 | Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study |
| Q40706475 | Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study |
| Q43085554 | Reply to "Younger age at cancer diagnosis may be driven by age structure of the HCV population". |
| Q36858838 | Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014. |
| Q40769735 | Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013. |
| Q36727043 | Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience |
| Q28545237 | Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing |
| Q92916687 | Temporal trends in liver cancer mortality by educational attainment in the United States, 2000-2015 |
| Q39506797 | The Burden of Hepatitis C Infection-Related Liver Fibrosis in the United States. |
| Q40660180 | The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts |
| Q64112066 | The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon’s multiple streams framework |
| Q64970808 | Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention. |
| Q42591044 | Trends in Liver Transplantation in Hepatitis C Virus-Infected Persons, United States |
| Q47437500 | Trends in hepatitis C-related mortality in Switzerland |
| Q38685582 | Universal screening for chronic hepatitis C virus |
| Q59133434 | Update on global epidemiology of viral hepatitis and preventive strategies |
| Q38669361 | Using Electronic Health Records for Population Health Research: A Review of Methods and Applications. |
| Q47300268 | Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers. |
Search more.